113 related articles for article (PubMed ID: 29796179)
1. Preoperative tumor size is associated with deep myometrial invasion and lymph node metastases and is a negative prognostic indicator for patients with endometrial carcinoma.
Nakamura K; Nakayama K; Ishikawa N; Minamoto T; Ishibashi T; Ohnishi K; Yamashita H; Ono R; Sasamori H; Razia S; Hossain MM; Kamrunnahar S; Ishikawa M; Kyo S
Oncotarget; 2018 May; 9(33):23164-23172. PubMed ID: 29796179
[TBL] [Abstract][Full Text] [Related]
2. Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.
Ytre-Hauge S; Husby JA; Magnussen IJ; Werner HM; Salvesen ØO; Bjørge L; Trovik J; Stefansson IM; Salvesen HB; Haldorsen IS
Int J Gynecol Cancer; 2015 Mar; 25(3):459-66. PubMed ID: 25628109
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
[TBL] [Abstract][Full Text] [Related]
4. High preoperative Glasgow prognostic score is a negative prognostic factor for patients with endometrial carcinoma.
Nakamura K; Nakayama K; Minamoto T; Ishibashi T; Sanuki K; Yamashita H; Ono R; Sasamori H; Komatsu-Fujii T; Ishikawa M; Kyo S
Mol Clin Oncol; 2018 Mar; 8(3):429-433. PubMed ID: 29456849
[TBL] [Abstract][Full Text] [Related]
5. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced MRI in preoperative assessment of myometrial and cervical invasion, and lymph node metastasis: diagnostic value and error analysis in endometrial carcinoma.
Teng F; Zhang YF; Wang YM; Yu J; Lang X; Tian WY; Jiang CX; Xue FX
Acta Obstet Gynecol Scand; 2015 Mar; 94(3):266-73. PubMed ID: 25545203
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
[TBL] [Abstract][Full Text] [Related]
8. MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer.
Dybvik JA; Fasmer KE; Ytre-Hauge S; Husby JHA; Salvesen ØO; Stefansson IM; Krakstad C; Trovik J; Haldorsen IS
Insights Imaging; 2022 Jan; 13(1):1. PubMed ID: 35000020
[TBL] [Abstract][Full Text] [Related]
9. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of intratumoral blood flow study in patients with endometrial carcinoma.
Cheng WF; Chen TM; Chen CA; Wu CC; Huang KT; Hsieh CY; Hsieh FJ
Cancer; 1998 May; 82(10):1881-6. PubMed ID: 9587120
[TBL] [Abstract][Full Text] [Related]
11. Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.
Stiekema A; Lok C; Korse CM; van Driel WJ; van der Noort V; Kenter GG; Van de Vijver KK
Virchows Arch; 2017 Jun; 470(6):655-664. PubMed ID: 28401338
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic efficacy of diffusion-weighted MRI for pre-operative assessment of myometrial and cervical invasion and pelvic lymph node metastasis in endometrial carcinoma.
Koplay M; Dogan NU; Erdogan H; Sivri M; Erol C; Nayman A; Karabagli P; Paksoy Y; Celik C
J Med Imaging Radiat Oncol; 2014 Oct; 58(5):538-46; quiz 648. PubMed ID: 25046775
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound Measurement of Tumor-Free Distance from the Serosal Surface as the Alternative to Measuring the Depth of Myometrial Invasion in Predicting Lymph Node Metastases in Endometrial Cancer.
Liro M; Śniadecki M; Wycinka E; Wojtylak S; Brzeziński M; Stańczak A; Wydra D
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441406
[TBL] [Abstract][Full Text] [Related]
15. Preoperative ultrasound study in predicting lymph node metastasis for endometrial cancer patients.
Cheng WF; Chen CA; Lee CN; Chen TM; Huang KT; Hsieh CY; Hsieh FJ
Gynecol Oncol; 1998 Dec; 71(3):424-7. PubMed ID: 9887243
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study.
Todo Y; Choi HJ; Kang S; Kim JW; Nam JH; Watari H; Tamakoshi A; Sakuragi N
Gynecol Oncol; 2013 Nov; 131(2):294-8. PubMed ID: 23954595
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery].
Ivanov S; Tomov S
Akush Ginekol (Sofiia); 2009; 48(3):14-9. PubMed ID: 20198758
[TBL] [Abstract][Full Text] [Related]
18. Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas.
Husby JA; Salvesen ØO; Magnussen IJ; Trovik J; Bjørge L; Salvesen HB; Haldorsen IS
Clin Radiol; 2015 May; 70(5):487-94. PubMed ID: 25639620
[TBL] [Abstract][Full Text] [Related]
19. Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases.
Rechichi G; Galimberti S; Signorelli M; Franzesi CT; Perego P; Valsecchi MG; Sironi S
AJR Am J Roentgenol; 2011 Jul; 197(1):256-62. PubMed ID: 21701038
[TBL] [Abstract][Full Text] [Related]
20. Preoperative serum tissue factor pathway inhibitor‑2 level as a prognostic marker for endometrial cancer.
Kawaguchi R; Maehana T; Yamanaka S; Miyake R; Kawahara N; Iwai K; Yamada Y; Kimura F
Oncol Lett; 2023 Nov; 26(5):463. PubMed ID: 37854864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
